1.
2.
Drug susceptibility testing of nontuberculous mycobacteria
by Ingen, Jakko van
Future microbiology, 2014, Vol.9 (9), p.1095-1110
3.
4.
Draft Genome Sequences of Mycobacterium kansasii Clinical Strains
by Borowka, P
Genome announcements (Washington, DC), 2017, Vol.5 (22), p.e00406-17-e00406-17
5.
A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study
by Walker, Timothy M
The Lancet infectious diseases, 2018, Vol.18 (4), p.431-440
6.
Draft Genome Sequences of Mycobacterium kansasii Strains 1010001454, 1010001458, 1010001468, 1010001493, 1010001495, and 1010001469, Isolated from Environmental Sources
by Strapagiel, D
Genome announcements (Washington, DC), 2016, Vol.4 (3), p.e00456-16
7.
Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort
by Zweijpfenning, Sanne
Respiratory medicine, 2017, Vol.131, p.220-224
8.
Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease
by Bakuła, Zofia
Respiratory medicine, 2018, Vol.139, p.91-100
9.
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence
by van Ingen, Jakko
Expert review of anti-infective therapy, 2013, Vol.11 (10), p.1065-1077
10.
FATE: the new partnership to Fight Against TB in Central and Eastern Europe
by Jagielski, Tomasz
The Lancet infectious diseases, 2017, Vol.17 (4), p.363-363
11.
XDR tuberculosis
by van Ingen, Jakko
The Lancet infectious diseases, 2011, Vol.11 (8), p.585-585
12.
Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study
by van Ingen, Jakko
The Lancet infectious diseases, 2017, Vol.17 (10), p.1033-1041
13.
14.
Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study
by van Ingen, Jakko
The Lancet infectious diseases, 2017, Vol.17 (10), p.1033-1041
15.
16.
XDR tuberculosis
by van Ingen, Jakko
The Lancet infectious diseases, 2011, Vol.11 (8), p.585-585
17.
Mycobacterial disease in patients with rheumatic disease
by Ingen, J. van
Nature clinical practice. Rheumatology, 2008, Vol.4 (12), p.649-656
18.
Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy
by Ingen, J. van
Nature clinical practice. Rheumatology, 2007, Vol.3 (7), p.414-9
